- CMS: Medicare and Medicaid Programs: CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program
- Public Inspection: CMS: Medicare and Medicaid Programs: CY 2026 Payment Policies under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program
- CMS: Medicare Program; Implementation of Prior Authorization for Select Services for the Wasteful and Inappropriate Services Reduction (WISeR) Model
- Public Inspection: CMS: Medicare Program: Implementation of Prior Authorization for Select Services for the Wasteful and Inappropriate Services Reduction Model
- CMS: Secretarial Comments on the CBE's (Battelle Memorial Institute) 2024 Activities: Report to Congress and the Secretary of the Department of Health and Human Services
- HHS: Patient Protection and Affordable Care Act: Marketplace Integrity and Affordability
- Public Inspection: HHS: Patient Protection and Affordable Care Act: Marketplace Integrity and Affordability
- Increased Risk of Cyber Threats Against Healthcare and Public Health Sector
- HRSA Announces Action to Lower Out-of-Pocket Costs for Life-Saving Medications at Health Centers Nationwide
- Announcing the 2030 Census Disclosure Avoidance Research Program
- Eight Hospitals Selected for First Cohort of Rural Hospital Stabilization Program
- CMS: Medicare Program; Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals and the Long-Term Care Hospital Prospective Payment System and Policy Changes and Fiscal Year 2026 Rates; Requirements for Quality Programs; and Other Policy Changes; Correction
- CMS: Medicare Program; Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals and the Long-Term Care Hospital Prospective Payment System and Policy Changes and Fiscal Year 2026 Rates; Requirements for Quality Programs; and Other Policy Changes; Correction
- CMS: Medicare and Medicaid Programs; Contract Year 2026 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly; Correction
- CMS: Medicare and Medicaid Programs; Contract Year 2026 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly; Correction
New Set of ACS Five-year Estimates Released; Report from PA State Data Center Published
A new set of five-year estimates from the U.S. Census Bureau’s American Community Survey (ACS) have been released today, providing data users with demographic and socio-economic data for all geographic areas.
With this year’s release, users can now compare estimates across three distinct periods of time. The newest estimates can be compared with other non-overlapping releases (i.e., 2010-2014 and 2005-2009) to show change over time.
The Pennsylvania State Data Center has developed a report that highlights trends in marital status across all three non-overlapping five-year periods. Some findings include that the percentage of individuals who were married decreased consistently in 39 counties across each five-year period while the percentage of individuals who were divorced increased in 39 counties during that time.
Perry County had the highest percentage of individuals who were currently married (excluding those separated) at 57.1% while Philadelphia County had the lowest (30.6%). Cameron County had the highest percentage of those who were divorced (15.5%) while Centre County had the lowest (7.3%).
For more information on marital status trends or the ACS Five-Year Estimates, click here to read the Data Center’s latest brief.
Center for Rural Pennsylvania Announces Funding for COVID-19 Projects
The Center for Rural Pennsylvania, a legislative agency that serves as a resource for rural policy research within the Pennsylvania General Assembly, is issuing a special Request for Proposals (RFP) for policy research related to COVID-19 in rural communities. Grant awards are made by the Center’s Board of Directors.
Please access the RFP for more information on topic details and submission guidelines. Proposals will be evaluated in two rounds. To be considered for the first round, proposals must be received by February 15, 2021. Proposals for the second round of funding must be received by March 30, 2021. The Center’s enabling legislation allows the Center to award grants to qualified faculty members of Pennsylvania State University, the Pennsylvania State System of Higher Education (PASSHE) universities, and the regional campuses of the University of Pittsburgh. A qualified faculty member must serve as the project director.
Rural Counties Face 5th Straight Week of Record Number of Covid-19 Deaths
The number of new rural deaths climbed by more than 30% last week, topping 3,000 in a one-week period for the first time. New infections last week remained just below the record number of new cases set three weeks ago.
The number of people from rural counties who died from Covid-19-related causes in a one-week period topped 3,000 for the first time last week, marking the fifth consecutive week of a record-setting number of fatalities.
Rural counties broke another record last week for the number of counties in the red zone, defined as 100 new cases per week per 100,000 residents. Ninety-four percent of rural counties (1,857 out of 1,976) exceeded that threshold last week. The red-zone definition comes from the White House Coronavirus Task Force and indicates that localities have lost control of the spread of the virus.
See examples of reports from the White House Coronavirus Task Force for and the nation.
The Daily Yonder’s weekly report on the coronavirus in rural America covers the period of Sunday, November 29, through Saturday, December 5.
- Rural counties reported 3,613 Covid-related deaths last week, an increase of 34% from the previous week, which also set a record for fatalities.
- Cumulatively, 38,172 rural Americans have died from the virus, representing just under 14% of all Covid-related deaths in the U.S. Rural residents (defined here as people living in nonmetropolitan counties) represents just over 14% of the U.S. population.
- The number of new infections was 211,960 last week, an increase of about 7% from the previous week. The record for new cases in rural counties (216,045) was set three weeks ago, just before Thanksgiving.
- Cumulatively, more than 2.2 million rural residents have tested positive for the coronavirus, representing 15.6% of all infections in the U.S.
- Although the rate of new infections continued to be worst in the Midwest, Great Plains, and Mountain West, all but a handful of U.S. counties (urban and rural) are in the red zone.
- About 4 out of every 10 rural counties had “very high” rates of new infections, defined as more than 500 per 100,000 in a week. These counties are shown in black on the map.
- About 3 out of 10 metropolitan counties had infection rates of more than 500 per 100,000 for the week. These counties are shown in dark blue on the map.
- Minnesota and Indiana each had more than 90% of their counties in the “very high” category.
- Illinois, Kansas, and South Dakota had more than 70% of all counties in the “very high” category.
- The rural rate of new infections and deaths remained higher in rural counties than in urban ones (see graphs below).
Pennsylvania Governor’s Administration Highlights Resources for Pennsylvanians as Opioid Crisis Continues to Affect Pennsylvania
Pennsylvania Governor Wolf’s Administration called for an end to the stigma surrounding the disease of addiction and highlighted the work that has been done by the administration in response to the ongoing opioid crisis.
“While the COVID-19 pandemic is occurring, many Pennsylvanians continue to struggle with the disease of addiction,” Deputy Secretary of Health Preparedness and Community Protection and Opioid Command Center Incident Commander Ray Barishansky said. “We know that a public health pandemic at the same time as the opioid epidemic has made for a challenging year for many. It is up to all of us to come alongside those who are struggling with the disease of addiction and to offer them our support. Treatment works, and recovery is possible.”
December is typically a challenging month for many who struggle with the disease of addiction. With the need for people to social distance and avoid gathering due to COVID-19, Pennsylvanians who have struggled with the disease of addiction may be at increased risk of relapsing this year.
The Department of Drug and Alcohol Programs (DDAP) maintains a toll-free helpline that connects callers looking for treatment options for themselves or a loved one to resources in their community. You can reach the Get Help Now helpline at 1-800-662-HELP (4357). The helpline is available 24/7 – including on Christmas Day. An anonymous chat service offering the same information to individuals who may not be comfortable speaking on the phone is also available at www.ddap.pa.gov.
“The most important thing for people to know is that there is hope through the help that is available for Pennsylvanians struggling with substance use disorder,” said DDAP Secretary Jennifer Smith. “Even during the pandemic, Pennsylvania’s drug and alcohol treatment providers are open and operational. If people are deciding whether to take that first, brave step, there is absolutely no shame in seeking help to lead a happy, healthy life. We must end the stigma associated with substance use disorder. Ending addiction stigma means saving Pennsylvania lives.”
In September, DDAP announced the launch of Life Unites Us, an anti-stigma campaign, utilizing social media platforms to spread real-life stories of individuals and their family members battling substance use disorder, live and recorded webinars detailing tools and information necessary to effectively reduce stigma to more than 350 community-based organizations focused on SUD prevention, treatment, and recovery throughout Pennsylvania, and a web-based interactive data dashboard detailing the progress of the campaign.
In addition to Life Unites Us, the administration is calling on all Pennsylvanians to carry naloxone.
Naloxone is carried at most pharmacies across the state year-round. Naloxone is available at pharmacies to many with public and private insurance either for free or at a low cost. In addition, naloxone has also been made available through the Pennsylvania Commission on Crime and Delinquency’s Centralized Coordinating Entities, free public naloxone giveaways at Pennsylvania Health Centers, partnerships with Pennsylvania colleges and universities, and distribution to narcotic treatment providers throughout the commonwealth.
The Opioid Command Center, established in January 2018 when Gov. Wolf signed the first opioid disaster declaration, meets every week to discuss the opioid crisis. The command center is staffed by personnel from 17 state agencies and the Office of the Attorney General, spearheaded by the departments of Health and Drug and Alcohol Programs.
Work to address the opioid crisis focuses on three areas: prevention, rescue and treatment. Efforts over the past several years, working with state agencies, local, regional and federal officials, have resulted in significant action to address the opioid crisis:
- Secretary of Health Dr. Rachel Levine signed an updated naloxone standing order permitting community-based organizations to provide naloxone by mail.
- The Prescription Drug Monitoring Program has reduced opioid prescriptions by 47 percent and has virtually eliminated doctor shopping.
- The number of people receiving high dosages of opioids (defined as greater than 90 morphine milligram equivalents per day) has dropped 57 percent since the PDMP launched in August 2016.
- The Opioid Data Dashboard and Data Dashboard 2.0 has provided public-facing data regarding prevention, rescue and treatment.
- 11 Pennsylvania Coordinated Medication Assisted Treatment (PacMAT) programs are serving as part of a hub-and-spoke model to provide evidence-based treatment to people where they live, with just under $26 million dedicated into the centers.
- More than 45 Centers of Excellence, administered by the Department of Human Services, provide coordinated, evidence-based treatment to people with an opioid use disorder covered by Medicaid. The COEs have treated more than 32,500 people since first launching in 2016.
- The waiver of birth certificate fees for those with opioid use disorder has helped more than 5,400 people, enabling easier entry into recovery programs.
- A standing order signed by Dr. Rachel Levine in 2018 allowed EMS to leave behind more than 2,400 doses of naloxone.
- Education has been provided to more than 7,000 prescribers through either online or face-to-face education.
- 882 drug take-back boxes help Pennsylvanians properly dispose of unwanted drugs, including 178,540 pounds of unwanted drugs in 2019. 2020 data is not yet available because of COVID.
- The Get Help Now Hotline received more than 44,000 calls, with more than half of all callers connected directly to a treatment provider.
- The state prison system has expanded their Medication Assisted Treatment (MAT) program, which is viewed as a model program for other states.
- A body scanner pilot project was successful in reducing overdoses and violent crime in a number of facilities. Body scanners are in place in more than 30 locations and are currently being expanded to additional facilities.
- Several agencies have worked together to collaborate on the seizure and destruction of illicit opioids across Pennsylvania.
- Education and training on opioids have been provided to schools. Future plans are in place to make opioid education a standard component of school-based training.
- The coordination with seven major commercial providers has expand access to naloxone and mental health care, while also working to make it more affordable.
- Naloxone has been made available to first responders through the Pennsylvania Commission on Crime and Delinquency since November 2017, with more than 72,000 kits made available and more than 16,241 overdose reversals reported through the program. More than 6,600 of those saves occurred in 2019.
- EMS have administered more than 47,000 doses of naloxone and more than 10,000 doses were made available to members of the public during the state’s naloxone distribution last year.
For more information on Pennsylvania’s response to the opioid crisis visit www.pa.gov/opioids.
It’s Not Too Late to Get the Flu Shot
It’s more important than ever for everyone to do their part to help prevent the spread of illnesses like the flu. Because of the COVID-19 pandemic, fewer people are getting vaccines which puts their communities at greater risk for other preventable diseases, like the flu. When people get the flu shot, it helps protect them and keeps them from spreading the flu to others.
Racial and ethnic minority groups are disproportionately affected when it comes to receiving recommended vaccines, due to such factors as vaccination safety concerns and limited access to care and coverage. During National Influenza Vaccination Week, the Centers for Medicare & Medicaid Service Office of Minority Health (CMS OMH), is highlighting vaccination disparities and reminding patients and their families that it’s not too late to get the flu vaccine.
CMS has developed new flu vaccination resources for partners, patients, providers, states, territories, tribes, and others who can share our message and help combat vaccine disparities. Please use our resources to encourage your patients to get their flu shot so they and their communities can stay healthy.
Resources
- Find vaccination resources for racial and ethnic minority patients, as well as resources for providers and partners that serve these populations at cms.gov/omhflu.
- Visit cms.gov/flu for a one-stop shop to help you find CMS’s flu vaccination information and resources.
- Looking for additional languages? Find postcards in 18 languages.
- Review our From Coverage to Care (C2C) resources to learn more about health coverage and find preventive resources.
- Visit the Beneficiary Care Management Program immunization webpage.
This communication was printed, published, or produced and disseminated at U.S. taxpayer expense.
In Case You Missed It: CMS Announces Guidance for Medicare Coverage of COVID-19 Antibody Treatment
On December 9, CMS posted updates to FAQs and an infographic about coverage and payment for monoclonal antibodies to treat COVID-19. The FAQs include general payment and billing guidance for these products, including questions on different setting types. The infographic has key facts about expected Medicare payment to providers and information about how Medicare beneficiaries can receive these innovative COVID-19 treatments with no cost-sharing during the public health emergency (PHE). CMS’ November 10, 2020 announcement about coverage of monoclonal antibody therapies allows a broad range of providers and suppliers, including freestanding and hospital-based infusion centers, home health agencies, nursing homes, and entities with whom nursing homes contract, to administer this treatment in accordance with the Food & Drug Administration’s Emergency Use Authorization (EUA), and bill Medicare to administer these infusions. Currently, two monoclonal antibody therapies have received EUA’s for treatment of COVID-19.
For More Information:
- Therapeutics Coverage Infographic
- Section BB of the FAQs: billing and payment for COVID-19 monoclonal antibody treatments
- Monoclonal toolkit and program guidance
HHS Summarizes Current Treatments Available to Treat Those Infected with the Virus
Helpful overviews include FDA Combating Covid-19 with Therapeutics and a video interview with the Operation Warp Speed lead on types of treatments and ongoing research.
- What treatments for COVID-19 are approved for use? As of Nov. 23, the FDA has approved one treatment for COVID-19, the antiviral drug Veklury (remdesivir), for use in adult and pediatric patients 12 years of age and older. Five other treatments are currently authorized for Emergency Use – including convalescent plasma and monoclonal antibodies.
- What’s the difference between convalescent plasma and monoclonal antibodies? Basically, monoclonal antibodies are laboratory-made proteins that mimic the immune system’s ability to fight off harmful antigens such as viruses. Convalescent plasma is from patients who have already recovered from COVID-19 and may contain antibodies against the virus.
- What other treatments are in development? FDA created the Coronavirus Treatment Acceleration Program (CTAP) to expedite the development of therapeutics. As of Oct. 31, there were more than 370 active trials and more than 560 development programs for therapeutic agents in the planning stages. Visit the CTAP’s dashboard.
- Why is there a national call for plasma? As COVID-19 infections spike nationwide, the demand for convalescent plasma is outpacing donations. Americans who have recovered from COVID-19 in the last three months can donate now. Visit local blood collection center, American Red Cross or America’s Blood Centers or visit org to become a donor.
HHS Announcements & News
Vaccine Development and Distribution Update
- CDC’s Advisory Committee on Immunization Practices (ACIP) met last week and voted on general recommendations for how to prioritize vaccine distribution when supply is initially scarce.
- CDC then published the MMWR with their vaccine priority recommendations to jurisdictions. Bottom line: The 24 million vaccines will first take care of the 21 million healthcare workers and then approximately 3 million seniors and frail living in long term care facilities second.
- The 64 jurisdictions are working on distribution plans and will use these recommendations and their own best judgment to develop allocation plans based on what makes sense in their circumstances.
- , Dec. 10, FDA’s Vaccine Advisory Board will meet to discuss an emergency use authorization request for Pfizer’s vaccine.
- , Dec. 17, FDA’s Vaccine Advisory board will review the clinical trial data submitted by Moderna for emergency authorization of its vaccine.
- What can we do? When vaccines become available, it’ll be our turn to get vaccinated and encourage our communities to do the same. Read and share the CDC’s website and videos with quick things to know about the science of vaccines.
New Study on First U.S. Cases of COVID-19
CDC highlighted a study that shows that the virus that causes COVID-19 may have been in the U.S. as early as mid-December 2019, a month before the first confirmed case, based on antibodies found in donated blood.
COVID-19 Infection, Hospitalizations, and Deaths Among Persons Hispanic/Latinos
CDC released an MMWR for the period between March and Oct. in Denver, Colorado. The majority of adult COVID-19 cases (55%), hospitalizations (62%), and deaths (51%) were among Hispanic adults, double the proportion of Hispanic adults (24.9%).
COVID-19 Emergency Webinar for Community Based Organizations: Vaccines
Wed., Dec. 16, 2020. 3:00 p.m. ET. Register here.
CDC Foundation President and CEO Dr. Judy Monroe, CDC Principal Deputy Director Dr. Anne Schuchat will discuss the current COVID-19 response, including the latest information about vaccines, and vaccine distribution plans. A local expert will also speak about vaccine-related challenges and opportunities.
Register now! USDA Faith Fellowship and Food Security Virtual Convening
USDA will host a Faith and Opportunity Fellowship convening bringing together faith leaders, faith-based organizations, and houses of worship to engage with peers, discuss common challenges, and hear best practices related to food security and community food system resilience. Register here. Reach out to alex.cordova@usda.gov with any questions.
CCMS Announces New Model to Advance Regional Value-Based Care in Medicare
Geographic Direct Contracting Model Builds on CMS’ Long-Standing Commitment to Improving Quality and Lowering Costs for Medicare Beneficiaries
The Centers for Medicare & Medicaid Services announced a new and transformative voluntary payment model that builds on CMS’ focus to deliver Medicare beneficiaries value through better care and improved quality. The Geographic Direct Contracting Model (the “Model”) will test an approach to improving health outcomes and reducing the cost of care for Medicare beneficiaries in multiple regions and communities across the country. Through the model, participants will take responsibility for beneficiaries’ health outcomes, giving participants a direct incentive to improve care across entire geographic regions. Within each region, organizations with experience in risk-sharing arrangements and population health will partner with health care providers and community organizations to better coordinate care.
Beneficiaries in the model will maintain all of their existing Original Medicare benefits, including the ability to see any provider they choose. Beneficiaries may also receive enhanced benefits, including additional telehealth services, easier access to home care, access to skilled nursing care without having to stay in a hospital for three days, and concurrent hospice and curative care. Participants will also have the ability to reduce beneficiary cost sharing for Medicare Part A and Part B services as well as offer beneficiaries a Part B premium subsidy. Lower out-of-pocket costs will allow participants to encourage beneficiaries to seek high-value care while maintaining the freedom and choice beneficiaries have in the Original Medicare program. While providers and participants may choose to voluntarily enter into value-based arrangements, the Model will not change how Medicare-enrolled providers care for beneficiaries in Original Medicare today.
“The need to strengthen the Medicare program by moving to a system that aligns financial incentives to pay for keeping people health has long been a priority,” said CMS Administrator Seema Verma. “This model allows participating entities to build integrated relationships with healthcare providers and invest in population health in a region to better coordinate care, improve quality, and lower the cost of care for Medicare beneficiaries in a community.”
Participants will work within defined geographic regions to maintain and improve care coordination, leveraging beneficiaries’ existing provider relationships as well as developing innovative care delivery solutions that take into account a region’s unique, local needs.
Specifically, Model participants will coordinate care and clinical management for beneficiaries in Original Medicare in their region. This coordination may include care management services, telemedicine, as well as help for beneficiaries to understand which providers have a history of delivering better results and lower costs over the long-term. Beneficiaries in the model will remain in Original Medicare and maintain all of their benefits and coverage rights. Beneficiaries will also keep all of the protections of Original Medicare, including access to all Medicare providers and suppliers, the freedom to choose and change providers at any time, and a strong appeals and Ombudsman system.
To help with delivering improved outcomes, participants may create a network of preferred providers, armed with the Model’s enhanced flexibilities to provide the right care for beneficiaries at a lower cost. Participants and preferred providers may choose to enter into alternative payment arrangements, including prospective capitation and other value-based arrangements. Participants will also work to augment Medicare’s current program integrity efforts, reducing fraud, waste, and abuse in their region and decreasing costs for beneficiaries and taxpayers.
“The Geographic Direct Contracting Model is part of the Innovation Center’s suite of Direct Contracting models and is one of the Center’s largest bets to date on value-based care,” said CMMI Director Brad Smith. “The model offers participants enhanced flexibilities and tools to improve care for Medicare beneficiaries across an entire region while giving beneficiaries enhanced benefits and the possibility of lower out-of-pocket costs. By initially testing the model in a small number of geographies, we will be able to thoughtfully learn how these flexibilities are able to impact quality and costs.”
Organizations that are potentially interested in participating in the Model should submit a non-binding Letter of Interest to CMS by 11:59pm PT, December 21, 2020 through this link: Geographic Direct Contracting Model Letter of Interest. Letters of Interest will be used to determine the final regions in which CMS will solicit participants.
The Request for Applications will be made available in January 2021, and Applications will be due on April 2, 2021. Model Participants will be selected by June 30, 2021. The first three-year performance period will run from January 1, 2022 through December 31, 2024. A second three-year performance period will run from January 1, 2025 through December 31, 2027.
For more information, please visit: https://www.cms.gov/newsroom/fact-sheets/geographic-direct-contracting-model-geo
Colorado Hospital Association Releases New Playbook for Rural Health Care Emergency Response
The Colorado Hospital Association (CHA) and its partners released a new resource to assist rural health care systems nationwide develop emergency response plans for COVID-19 and beyond. This playbook, Re-imagining Leadership: A Pathway for Rural Health to Thrive in a COVID-19 World, seeks to empower rural health care leaders create tailored responses that take the unique identities of their communities into account.
Rural communities nationwide have been particularly hard-hit by the COVID-19 pandemic, and the disparities facing rural health care systems are more apparent now than ever. Creating a meaningful resource to assist rural health care leaders weather these challenges requires the insight and direction of those on the frontlines within those communities. With that in mind, CHA and its partners distilled dozens of personal interviews, extensive literature review and an analysis of rural health care data into this playbook.
“There can be no scripted guide or silver bullet to address the unique challenges faced by each rural community,” said Benjamin Anderson, CHA vice president of rural health and hospitals. “That is why this playbook offers a framework that can be tailored to fit the individual strengths, challenges and identities of our rural partners here in Colorado and across the country.”
CHA was proud to partner with the Eugene S. Farley, Jr. Health Policy Center at the University of Colorado Anschutz Medical Campus on this playbook, which was made possible by generous funding from the ZOMA Foundation and CPSI.
About Colorado Hospital Association
Colorado Hospital Association (CHA) is the leading voice of Colorado’s hospital and health system community. Representing more than 100 member hospitals and health systems throughout the state, CHA serves as a trusted, credible and reliable resource on health issues, hospital data and trends for its members, media, policymakers and the general public. Through CHA, Colorado’s hospitals and health systems work together in their shared commitment to improve health and health care in Colorado.
Updated COVID-19 Funding Sources Impacting Rural Providers Released
The Technical Assistance and Services Center (TASC), in coordination with the Federal Office of Rural Health Policy (FORHP), are pleased to provide another update of the COVID-19 Funding Sources Impacting Rural Providers guide. This funding resource is intended to support rural health care providers, along with their state and local partners, navigate the availability of federal funds to support the novel coronavirus (COVID-19) pandemic response and recovery efforts. This guide is updated regularly to capture changes in funding sources.
Seven tables, or matrices, are provided for quick reference at the beginning of this resource. The tables can be used to check eligibility of participation in funding sources by provider types: rural prospective payment system (PPS) and critical access hospitals (CAH), rural health clinics (RHC), federally qualified health centers (FQHC), long-term care (LTC) or skilled nursing facilities (SNF), tribal facilities, and emergency medical services (EMS). The tables also provide an at-a-glance view for each provider type sharing the different types of funds that may be accessed from various funding sources dependent on their participation eligibility. Each funding source is described in its own section of this resource with an executive summary followed by further detail on the use of funds, reporting requirements, hyperlinks to the legislation and detailed information.
One of the main updates for this version is the addition of the RHC COVID-19 Testing Program found on Page 57.
The guide can be found in COVID-19 Collection located on The National Rural Health Resource Center’s website. This collection consists of trusted and reliable resources, such as the COVID-19 Funding Sources Impacting Rural Providers Guide, along with standing links to additional organizations’ COVID-19 resources, FAQs, webinars, tools, and trainings. The Center aims to help direct the most up-to-date and relevant tools and resources to rural hospitals, clinics, and their communities. This Collection will be updated regularly to help assist with the abundance of circulating information relating to COVID-19.